MVASI

This brand name is authorized in Austria, Australia, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Turkey, United States

Active ingredients

The drug MVASI contains one active pharmaceutical ingredient (API):

1 Bevacizumab UNII 2S9ZZM9Q9V - BEVACIZUMAB

Bevacizumab binds to vascular endothelial growth factor (VEGF), the key driver of vasculogenesis and angiogenesis, and thereby inhibits the binding of VEGF to its receptors, Flt-1 (VEGFR-1) and KDR (VEGFR-2), on the surface of endothelial cells. Neutralising the biological activity of VEGF regresses the vascularisation of tumours, normalises remaining tumour vasculature, and inhibits the formation of new tumour vasculature, thereby inhibiting tumour growth. Read about Bevacizumab

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01FG01	Bevacizumab	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FG VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors
Discover more medicines within L01FG01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 12479T, 12508H
Country: CA	Health Products and Food Branch	Identifier(s): 02470748, 02470756
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 175-MBE-0121
Country: EE	Ravimiamet	Identifier(s): 1762657, 1762668
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1171246001, 1171246002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 484229, 573402
Country: FR	Base de données publique des médicaments	Identifier(s): 61409314
Country: HK	Department of Health Drug Office	Identifier(s): 67028, 67029
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8967, 8970
Country: IT	Agenzia del Farmaco	Identifier(s): 045925017, 045925029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1084945, 1084946
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 76910, 76929
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 20772, 20773
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100400713
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66673001, W66673002
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699862760034, 8699862760041
Country: US	FDA, National Drug Code	Identifier(s): 55513-206, 55513-207